Matt, Author at European Medical Journal - Page 206 of 212

Investigating the Different Dimensions of DPP-4 Inhibitors

This Takeda-sponsored European Association for the Study of Diabetes (EASD) symposium addressed the pharmacology, clinical use, and future therapeutic…

Diffusion Tensor Imaging Of the Brain in Type 1 Diabetes

Individuals with Type 1 diabetes mellitus (T1DM) are required to carefully manage their insulin dosing, dietary intake, and activity levels in order to…

Detection and Early Lifestyle Intervention in Those at Risk of Type 2 Diabetes

The prevalence of Type 2 diabetes mellitus (T2DM) has reached epidemic proportions in recent years. It is now widely recognised that T2DM…

A Practical Review of Insulin Pen Devices

Since the advent of insulin pens in 1985, there have been ongoing improvements providing several advantages over the traditional vial and syringe method…

Membrane Flexibility and Cellular Energy Management in Type 2 Diabetes, Gestational Diabetes, and Obesity

In the search to understand the onset of life’s biochemistry, scientists attached a great deal of importance to unravelling the replication mechanism of…

Targeting Adipose Tissue Lipid Metabolism to Improve Glucose Metabolism in Cardiometabolic Disease

With Type 2 diabetes mellitus and cardiovascular disease prevalence on the rise, there is a growing need for improved strategies to prevent or treat…

Residual Cardiovascular Risk in Diabetic Patients: The Role of Fibrate Statin Combination

Patients with Type 2 diabetes mellitus (T2DM) have increased cardiovascular disease (CVD) risk. The use of statins significantly reduces the rate of CVD…

Pathophysiology and Imaging Techniques of Diabetic Heart Disease

Diabetic patients are at an increased risk of developing heart failure. The aetiology of diabetic heart disease is likely to be multifactorial…

Exercise: A Powerful Tool to Manage Type 2 Diabetes in the Ageing Population

The aim of this paper is to highlight the evidence on the interrelationships between exercise and Type 2 diabetes mellitus (T2DM) in the ageing population.

Who Gets Diabetic Macular Oedema; When; and Why? Pathogenesis and Risk Factors

Diabetic macular oedema (DMO) presents an enormous rise in the last decades with an increasing number of diabetic patients.